@FierceMedDev: ICYMI yesterday: Brain-controlled, robotic prosthetic hand comes closer to simulating reality. Article | Follow @FierceMedDev
@VarunSaxena2: Irish research center wins EU funding to study and develop transdermal delivery methods. More from FierceDrugDelivery | Follow @VarunSaxena2
@EmilyWFierce: Some background info on liquid biopsies. More from MIT Technology Review | Follow @EmilyWFierce
> Oncology imaging analysis company HealthMyne has raised a $4.5 million Series A round led by Madison, WI-based venture firms Venture Investors and 4490 Ventures. More
> Medtronic ($MDT) has been hit by a whistleblower lawsuit from a former employee who says she was fired after reporting that the company was allowing untrained staff to perform medical procedures. Story
> Cardiac Dimensions has added $15.2 million to raise a total of $43 million in a previously disclosed financing. The round is backing a European and Australian trial of the company's percutaneous mitral repair device in patients with functional mitral regurgitation. More
> Zimmer ($ZMH) is raising $7.65 billion in debt to help finance its $13.4 billion acquisition of Biomet, which is slated to close this quarter. Release
Biotech News
@FierceBiotech: Acadia craters as takeover buzz is silenced by news of an unexpected NDA delay, CEO exit. Article | Follow @FierceBiotech
@JohnCFierce: 4 of the last Fierce 15 have filed IPOs since last fall. More coming. Hot market, eh? Feature | Follow @JohnCFierce
@DamianFierce: Here's the $ENDP letter to $SLXP's board, pitching a deal that's 74% stock. PDF | Follow @DamianFierce
> Epizyme retrieves global rights to cancer drug in $110M deal. News
> Neuralstem tanks on cloudy results for its ALS treament. Story
> 23andMe dives into biotech with Genentech R&D star Richard Scheller on board. Report
Pharma News
@FiercePharma: Gates Foundation puts $52 million behind CureVac, following Sanofi, Boehringer's lead. FierceVaccines story | Follow @FiercePharma
@EricPFierce: Texas drug compounder corralled by federal injunction. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Should Teva buy Mylan? 'Close call,' analyst says. Report | Follow @CarlyHFierce
> Endo aims to lure Salix from Valeant with $175-per-share offer. Report
> J&J boosts CEO pay to $25M, doubles R&D chief's haul. Article
Vaccines News
> Analyst: Ebola vaccine developers 'need to weigh risks' as cases dwindle. More
> Combo-happy Diamyd launches new diabetes vaccine trial in children. Report
> Smallpox vaccine helps Bavarian Nordic net first full-year profit in 5 years. Story
> Takeda transfers HPV vaccine rights as it continues globalization push. More
> Bharat's $1 rotavirus vaccine rolls out in India to challenge GSK, Merck. Article
Pharma Manufacturing News
> Hikma profits soften as shortages of doxycycline are resolved. Article
> Mylan recalls drug after problem uncovered with Indian supplier. Item
> Texas compounder corralled by federal injunction. More
> Pfizer makes it official, it has reversed its decision to close Irish Lipitor plant. Story
> Manufacturing mess at J&J consumer plant results in guilty plea, $20M fine. Report
Pharma Asia News
> AstraZeneca and Singapore's A*STAR ink research pact on complex heart failure syndrome. More
> Biotech in China is built brick-by-brick, but more money would help, BeiGene's Oyler says. Article
> First off the blocks, Natco gets India's regulatory nod for hep C copy. Story
> Japan a lucrative market for endocrine sales, report says. Item
> Glaxo plants a flag in Singapore with CEO Witty on hand. Report